ARCHIVES

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

January 28, 1994

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007

DCCP Board Okays New, Recompeting Contracts Worth $4.6 Million In ‘81

October 17, 1980

In Brief: Chemical Carcinogenesis, Epidemiology Trail Viral Oncology In Budget Growth, Board Notes

November 7, 1980

Harvest Yet To Come From Radiotherapy Advances, Kaplan Tells NCAB

October 17, 1975

House panel investigating NIH handling of tissue specimens.

June 24, 2005